Assessment of Oral and Nasal Breathing With Sensors Analyzing Algorithm
Launched by OULU UNIVERSITY HOSPITAL · May 11, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how well a new method of measuring breathing—using sensors and an algorithm—compares to a traditional technique called body plethysmography. The goal is to see if the new method is accurate enough to help identify breathing issues in both healthy adults and those with conditions like asthma, chronic obstructive pulmonary disease (COPD), and nasal polyps. Participants will perform a short breathing test while their breathing is monitored using both methods to gather data.
To be eligible for this study, participants should be between the ages of 65 and 74. The trial is looking for five healthy volunteers as well as five individuals each with allergic rhinitis, asthma, or COPD, all of whom must have a confirmed diagnosis. Participants can expect to wear different masks during the breathing tests, but there are some exclusions to keep in mind, such as recent surgeries or certain health conditions that could affect safety. Overall, this study aims to improve the accuracy of breathing assessments, which could lead to better care for those with respiratory issues.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 5 healthy and asymptomatic volunteers with regard to lungs and nose
- • 5 patients with allergic rhinitis or nasal polyps (diagnosis of allergic rhinitis confirmed by a PRICK test or specific Ig E antibody tests and Nasal polyposis diagnosed by an ENT specialist, with endoscopy)
- • 5 patients with asthma (diagnosis of asthma based on peak expiratory flow (PEF) monitoring, spirometry, or other appropriate objective measurement methods performed by a pulmonologist
- • 5 patients with Chronic Obstructive Pumonary Disease (diagnosis of COPD based on spirometry (post-bronchodilator Forced Expiratory Volume/ Forced Vital Capacity (FEV1/FVC) ratio below 0.70)
- Exclusion Criteria:
- • Pregnancy.
- • History of surgical procedures in the chest, larynx, throat (excluding tonsillectomy), or nasal area.
- * Recent illnesses or surgeries that pose a risk to the patient or prevent proper measurement (common contraindications for spirometry):
- • Recent (\<1 month) myocardial infarction.
- • Severe coronary artery disease with easily triggered symptoms.
- • Cerebral artery aneurysm.
- • Recent brain (\<4 weeks) or eye (\<1 week) surgery.
- • Severe cardiac arrhythmias.
- • Pulmonary tuberculosis.
- • Pneumothorax
- • Immediate postoperative period of lung surgery (\<1 day).
- • Dementia or confusion.
About Oulu University Hospital
Oulu University Hospital is a leading academic medical center located in Oulu, Finland, dedicated to advancing healthcare through innovative clinical research and education. As a sponsor of clinical trials, the hospital leverages its robust infrastructure, interdisciplinary expertise, and commitment to patient-centered care to facilitate groundbreaking studies across various medical disciplines. By fostering collaboration between researchers, healthcare professionals, and patients, Oulu University Hospital aims to translate scientific discoveries into effective treatments and improve health outcomes, contributing to the global advancement of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oulu, , Finland
Patients applied
Trial Officials
Olli-Pekka Alho, Prof
Principal Investigator
University of Oulu, Finland
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported